Associated Papers
Reassessing the role of the p.(Arg304Gln) missense AIP variant in pituitary tumorigenesis.
Loughrey PB et al.
European Journal of Endocrinology, 2025
Risk category system to identify pituitary adenoma patients with AIP mutations.
Caimari F et al.
Journal of Medical Genetics, 2018
Genetic Aspects of Pituitary Adenomas.
Marques P et al.
Endocrinology and Metabolism Clinics of North America, 2017
Sporadic pituitary adenomas: the role of germline mutations and recommendations for genetic screening.
Iacovazzo D et al.
Expert Review of Endocrinology & Metabolism, 2017
The role of AIP mutations in pituitary adenomas: 10 years on.
Daly AF et al.
Endocrine, 2017
Impact of AIP and inhibitory G protein alpha 2 proteins on clinical features of sporadic GH-secreting pituitary adenomas.
Ritvonen E et al.
European Journal of Endocrinology, 2017
Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers.
Hernández-Ramírez LC et al.
The Journal of Clinical Endocrinology and Metabolism, 2015
Do the aryl hydrocarbon receptor interacting protein variants (Q228K and Q307R) play a role in patients with familial and sporadic hormone-secreting pituitary adenomas?
Yarman S et al.
Genetic Testing and Molecular Biomarkers, 2015
AIP inactivation leads to pituitary tumorigenesis through defective Gαi-cAMP signaling.
Tuominen I et al.
Oncogene, 2015
The AIP (aryl hydrocarbon receptor-interacting protein) gene and its relation to the pathogenesis of pituitary adenomas.
Lloyd C et al.
Endocrine, 2014
Familial acromegaly due to aryl hydrocarbon receptor-interacting protein (AIP) gene mutation in a Turkish cohort.
Niyazoglu M et al.
Pituitary, 2014
Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma.
Zhou Y et al.
Molecular and Cellular Endocrinology, 2014
Screening for AIP gene mutations in a Han Chinese pituitary adenoma cohort followed by LOH analysis.
Cai F et al.
European Journal of Endocrinology, 2013
Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.
Beckers A et al.
Endocrine Reviews, 2013
Familial isolated pituitary adenomas: an emerging clinical entity.
Martucci F et al.
Journal of Endocrinological Investigation, 2012
Genetic susceptibility in pituitary adenomas: from pathogenesis to clinical implications.
Jaffrain-Rea ML et al.
Expert Review of Endocrinology & Metabolism, 2011
Familial isolated pituitary adenomas: from genetics to therapy.
Guaraldi F et al.
Clinical and Translational Science, 2011
Clinical features and treatment of pediatric somatotropinoma: case study of an aggressive tumor due to a new AIP mutation and extensive literature review.
Personnier C et al.
Hormone Research in Paediatrics, 2011
The R304X mutation of the aryl hydrocarbon receptor interacting protein gene in familial isolated pituitary adenomas: Mutational hot-spot or founder effect?
Occhi G et al.
Journal of Endocrinological Investigation, 2010
AIP gene and familial isolated pituitary adenomas.
Ozfirat Z et al.
Molecular and Cellular Endocrinology, 2010
Role of the aryl hydrocarbon receptor-interacting protein in familial isolated pituitary adenoma.
Cain JW et al.
Expert Review of Endocrinology & Metabolism, 2010
Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families.
Igreja S et al.
Human Mutation, 2010
The expression of AIP-related molecules in elucidation of cellular pathways in pituitary adenomas.
Heliövaara E et al.
The American Journal of Pathology, 2009
Aggressive pituitary adenomas occurring in young patients in a large Polynesian kindred with a germline R271W mutation in the AIP gene.
Jennings JE et al.
European Journal of Endocrinology, 2009
The epidemiology and genetics of pituitary adenomas.
Daly AF et al.
Best Practice & Research. Clinical Endocrinology & Metabolism, 2009
[Genetics of familial pituitary adenomas].
Beckers A et al.
Bulletin De L'academie Nationale De Medecine, 2009
Familial pituitary tumor syndromes.
Elston MS et al.
Nature Reviews. Endocrinology, 2009
Familial pituitary adenomas.
Tichomirowa MA et al.
Journal of Internal Medicine, 2009
Mutations of the gene for the aryl hydrocarbon receptor-interacting protein in pituitary adenomas.
Cazabat L et al.
Hormone Research, 2009
The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas.
Leontiou CA et al.
The Journal of Clinical Endocrinology and Metabolism, 2008
Characteristics of familial isolated pituitary adenomas.
Daly AF et al.
Expert Review of Endocrinology & Metabolism, 2007
The clinical, pathological, and genetic features of familial isolated pituitary adenomas.
Beckers A et al.
European Journal of Endocrinology, 2007
No evidence of somatic aryl hydrocarbon receptor interacting protein mutations in sporadic endocrine neoplasia.
Raitila A et al.
Endocrine-related Cancer, 2007
Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas.
Cazabat L et al.
European Journal of Endocrinology, 2007
AIP gene in pituitary adenoma predisposition.
Vahteristo P et al.
Expert Review of Endocrinology & Metabolism, 2007
[Familial pituitary adenomas: clinical and genetic aspects].
Bricaire L et al.
Annales D'endocrinologie, 2007
Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families.
Daly AF et al.
The Journal of Clinical Endocrinology and Metabolism, 2007
Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas.
Barlier A et al.
The Journal of Clinical Endocrinology and Metabolism, 2007
Susceptibility to pituitary neoplasia related to MEN-1, CDKN1B and AIP mutations: an update.
Karhu A et al.
Human Molecular Genetics, 2007
The aryl hydrocarbon receptor-interacting protein gene is rarely mutated in sporadic GH-secreting adenomas.
Iwata T et al.
Clinical Endocrinology, 2007
AIP Mutations are not identified in patients with sporadic pituitary adenomas.
DiGiovanni R et al.
Endocrine Pathology, 2007
Aryl hydrocarbon receptor-interacting protein and acromegaly.
Aaltonen LA
Hormone Research, 2007
Aryl hydrocarbon receptor interacting protein variants in sporadic pituitary adenomas.
Yu R et al.
The Journal of Clinical Endocrinology and Metabolism, 2006
Pituitary adenoma predisposition caused by germline mutations in the AIP gene.
Vierimaa O et al.
Science (new York, N.y.), 2006
[Familial acromegaly. Apropos of a case. Review of the literature].
Tamburrano G et al.
Annales D'endocrinologie, 1992
Genetics of gigantism and acromegaly.
Hannah-Shmouni F et al.
Growth Hormone & Igf Research : Official Journal of the Growth Hormone Research Society and the International Igf Research Society, 0